Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England.
Requena G, Czira A, Banks V, Wood R, Tritton T, Castillo CM, Yeap J, Wild R, Compton C, Rothnie KJ, Herth F, Quint JK, Ismaila AS. Requena G, et al. Among authors: tritton t. Int J Chron Obstruct Pulmon Dis. 2023 Jul 13;18:1431-1444. doi: 10.2147/COPD.S411437. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 37465818 Free PMC article.
Cardiovascular risk profiles: A cross-sectional study evaluating the generalizability of the glucagon-like peptide-1 receptor agonist cardiovascular outcome trials REWIND, LEADER and SUSTAIN-6 to the real-world type 2 diabetes population in the United Kingdom.
Webb J, Mount J, von Arx LB, Rachman J, Spanopoulos D, Wood R, Tritton T, Massey O, Idris I. Webb J, et al. Among authors: tritton t. Diabetes Obes Metab. 2022 Feb;24(2):289-295. doi: 10.1111/dom.14580. Epub 2021 Nov 24. Diabetes Obes Metab. 2022. PMID: 34668637 Free PMC article.
Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist Dual Therapy in a Primary Care Setting in England.
Requena G, Banks V, Czira A, Wood R, Tritton T, Wild R, Compton C, Duarte M, Ismaila AS. Requena G, et al. Among authors: tritton t. Int J Chron Obstruct Pulmon Dis. 2022 Aug 10;17:1781-1795. doi: 10.2147/COPD.S365480. eCollection 2022. Int J Chron Obstruct Pulmon Dis. 2022. PMID: 35983168 Free PMC article.
Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β2-agonist dual therapy in a primary care setting in England.
Czira A, Banks V, Requena G, Wood R, Tritton T, Wild R, Compton C, Duarte M, Ismaila AS. Czira A, et al. Among authors: tritton t. BMJ Open Respir Res. 2022 Sep;9(1):e001243. doi: 10.1136/bmjresp-2022-001243. BMJ Open Respir Res. 2022. PMID: 36171051 Free PMC article.
Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting.
Halpin DMG, Rothnie KJ, Banks V, Czira A, Compton C, Wood R, Tritton T, Massey O, Wild R, Snowise N, Nikitin K, Sharma R, Ismaila AS, Vogelmeier CF. Halpin DMG, et al. Among authors: tritton t. Int J Chron Obstruct Pulmon Dis. 2022 Sep 24;17:2417-2429. doi: 10.2147/COPD.S370540. eCollection 2022. Int J Chron Obstruct Pulmon Dis. 2022. PMID: 36185170 Free PMC article.
Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β2-Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England.
Requena G, Banks V, Czira A, Wood R, Tritton T, Wild R, Compton C, Ismaila AS. Requena G, et al. Among authors: tritton t. Int J Chron Obstruct Pulmon Dis. 2023 Mar 5;18:231-245. doi: 10.2147/COPD.S389281. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 36908830 Free PMC article.
Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β2-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England.
Czira A, Requena G, Banks V, Wood R, Tritton T, Castillo CM, Yeap J, Wild R, Compton C, Rothnie KJ, Herth F, Quint JK, Ismaila AS. Czira A, et al. Among authors: tritton t. Int J Chron Obstruct Pulmon Dis. 2023 Apr 19;18:643-659. doi: 10.2147/COPD.S405498. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 37155496 Free PMC article.
93 results